HEALTH● LOWJul 23 · Jul 23, 2026, 11:23 AM
Lenacapavir will slow HIV infections if there's enough of it and it reaches at-risk groups
DW News [en]
Lenacapavir is one injection, twice a year. It's a big improvement for people in high-risk groups, currently taking a pill a day against HIV infection. But its long-term impact depends on it reaching those very people.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH25m agoLaunch of virtual autopsy at Kozhikode Medical College Hospital likely to take timeThe HinduHEALTH51m agoDuchess Hospital marks five years of giant milestonesPremium TimesHEALTH52m agoPsychology says that when getting to know someone, some people pay attention to details that go beyond first impressions. They observe how they treat others, if they keep their promises, and how they respond when a disagreement or an unexpected situation arises.ClarínHEALTH56m agoWhat to know about new guidance on GLP-1 use during pregnancyCBS News